| Product Code: ETC8390584 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Montenegro Lung Cancer Therapeutics Market Overview |
3.1 Montenegro Country Macro Economic Indicators |
3.2 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Montenegro Lung Cancer Therapeutics Market - Industry Life Cycle |
3.4 Montenegro Lung Cancer Therapeutics Market - Porter's Five Forces |
3.5 Montenegro Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Montenegro Lung Cancer Therapeutics Market Revenues & Volume Share, By Molecule Type, 2021 & 2031F |
3.7 Montenegro Lung Cancer Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Montenegro Lung Cancer Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
4 Montenegro Lung Cancer Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Montenegro |
4.2.2 Growing awareness about early detection and treatment options |
4.2.3 Advancements in lung cancer therapeutics and technologies |
4.3 Market Restraints |
4.3.1 High cost associated with lung cancer treatments |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Montenegro |
4.3.3 Stringent regulations and approval processes for new therapeutics |
5 Montenegro Lung Cancer Therapeutics Market Trends |
6 Montenegro Lung Cancer Therapeutics Market, By Types |
6.1 Montenegro Lung Cancer Therapeutics Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021- 2031F |
6.1.4 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Metastatic Lung Cancer, 2021- 2031F |
6.1.5 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Pulmonary Neuroendocrine Tumors, 2021- 2031F |
6.1.6 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Mediastinal Tumors, 2021- 2031F |
6.1.7 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Mesothelioma, 2021- 2031F |
6.1.8 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Chest Wall Tumors, 2021- 2031F |
6.2 Montenegro Lung Cancer Therapeutics Market, By Molecule Type |
6.2.1 Overview and Analysis |
6.2.2 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Biologics, 2021- 2031F |
6.3 Montenegro Lung Cancer Therapeutics Market, By Drug Class |
6.3.1 Overview and Analysis |
6.3.2 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Alkylating Agents, 2021- 2031F |
6.3.3 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.3.4 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By EGFR Inhibitors, 2021- 2031F |
6.3.5 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Mitotic Inhibitors, 2021- 2031F |
6.3.6 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Multikinase Inhibitors, 2021- 2031F |
6.4 Montenegro Lung Cancer Therapeutics Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.3 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.4.4 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.4.5 Montenegro Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
7 Montenegro Lung Cancer Therapeutics Market Import-Export Trade Statistics |
7.1 Montenegro Lung Cancer Therapeutics Market Export to Major Countries |
7.2 Montenegro Lung Cancer Therapeutics Market Imports from Major Countries |
8 Montenegro Lung Cancer Therapeutics Market Key Performance Indicators |
8.1 Number of new lung cancer cases diagnosed annually in Montenegro |
8.2 Adoption rate of innovative lung cancer therapies in Montenegro |
8.3 Survival rates of lung cancer patients in Montenegro |
9 Montenegro Lung Cancer Therapeutics Market - Opportunity Assessment |
9.1 Montenegro Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Montenegro Lung Cancer Therapeutics Market Opportunity Assessment, By Molecule Type, 2021 & 2031F |
9.3 Montenegro Lung Cancer Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.4 Montenegro Lung Cancer Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10 Montenegro Lung Cancer Therapeutics Market - Competitive Landscape |
10.1 Montenegro Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Montenegro Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here